BIOIDENT Wins Illustrious 2007 Wall Street Journal Technology Innovation
Awards
Printed Semiconductor-Based Technology Named Co-Winner for Breakthrough
Lab-on-a-Chip with Real-Time Results
BIOIDENT Technologies Inc., the leading company in the development of
printed opto-electronic solutions for life sciences, today announced that
the company is a co-winner in the semiconductor category for the seventh
annual Wall Street Journal contest for Technology Innovation. BIOIDENT was
awarded for the development of its PhotonicLab(TM) Platform, which enables
rapid in-vitro diagnostics, chemical and biological threat detection, and
environmental testing without the need for off-site lab analysis.
"We are delighted to win this prestigious award that recognizes our
innovative work on the cutting edge of nanotechnology," said Dr. Wasiq
Bokhari, CEO for BIOIDENT. "Once again, BIOIDENT is being acknowledged as
the pioneer in applying its unique printed opto-electronics to real-world
applications. We will continue to leverage our unique technology to develop
new solutions to address major industry challenges."
Utilizing the latest breakthroughs in science and nanotechnology, the
BIOIDENT PhotonicLab Platform is used to produce the world's first
disposable photonic lab-on-a-chip solution for next-generation mobile
analytics applications, such as water and food analysis, chemical and
biological agent detection, and point-of-care diagnostics. BIOIDENT employs
a process developed by its parent company, Austria's NANOIDENT Technologies
AG, for using an inkjet printer to print electronic circuits on a variety of
surfaces, such as plastic foil or glass; the technology makes it possible to
apply photosensitive semiconductors directly onto a lab-on-a-chip. The
Platform eliminates the need for complex and expensive readout systems and
delivers unprecedented mobility and sensitivity based on existing biological
and chemical assays.
About The Wall Street Journal Technology Innovation Awards
As part of the 2007 award nomination process, The Wall Street Journal
screened more than 800 applications, narrowing the field to about 150
entries. A panel of 13 judges picked category winners and runners-up in 12
different entry categories including computing systems, energy, environment,
materials and other base technologies, media/broadcasting, medical research,
medical devices, network/internet technologies, network security,
semiconductors, software and transport. Each entrant was required to offer
extensive details and explain why the entry merited consideration. Judging
criteria included innovativeness, clarity of explanation, whether the
innovation was covered by patents and if it had achieved some measure of
success. Factors the panel considered included: the innovation should have
gone well beyond what already existed and cannot simply represent
incremental improvements; it needed to address major challenges for which
new solutions would have a wide-ranging impact in a particular industry; the
written application needed to be supported by rigorous data rather than
unsubstantiated claims of potential.
About BIOIDENT Technologies Inc.
BIOIDENT is the leader in the development of rapid, multi-assay and mobile
analytical and diagnostic systems. BIOIDENT integrates highly sensitive
printed photodetectors and electronics with various existing Lab-on-a-Chip
(LOC) technologies including lateral flow, microfluidics and microarrays.
BIOIDENT's systems are designed for applications in in-vitro diagnostics,
chemical and biological threat detection, and environmental testing.
BIOIDENT's award-winning PhotonicLab(TM) Technology Platform eliminates the
need for complex and expensive readout systems and delivers unprecedented
mobility and sensitivity based on existing biological and chemical assays.
Benefits for BIOIDENT's customers and partners include high mobility, rapid
testing, multiplexing and low cost of ownership.
BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies AG, the
world leader in printed opto-electronics. The company is privately held with
headquarters in Menlo Park, California. BIOIDENT leverages NANOIDENT's
SEMICONDUCTOR 2.0(TM) Platform technology and its high-speed manufacturing
process, which uses liquid conductive and semi-conductive materials to print
electronic circuits on almost any surface using an inkjet printer. NANOIDENT
also has the world's only dedicated organic fabrication facility with a
production output of 40,000 sq.m per year. For more information about the
company, please visit www.bioident.com.
Bill Austin [EMAIL PROTECTED] http://www.azhttp.com/
Vice President of Business Development, AZhttp, Inc.
LinkedIn Profile: http://www.linkedin.com/in/billaustin
